M Bua

426 total citations
7 papers, 311 citations indexed

About

M Bua is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, M Bua has authored 7 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in M Bua's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). M Bua is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). M Bua collaborates with scholars based in United Kingdom and Italy. M Bua's co-authors include Jane F. Apperley, Richard Szydlo, David Marin, Eduardo Olavarría, John M. Goldman, Amin Rahemtulla, Jaspal Kaeda, Francesco Dazzi, Hugues de Lavallade and J M Goldman and has published in prestigious journals such as International Journal of Molecular Sciences, Leukemia and Haematologica.

In The Last Decade

M Bua

7 papers receiving 300 citations

Peers

M Bua
M Bua
Citations per year, relative to M Bua M Bua (= 1×) peers Takashi Kumagai

Countries citing papers authored by M Bua

Since Specialization
Citations

This map shows the geographic impact of M Bua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bua more than expected).

Fields of papers citing papers by M Bua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bua. The network helps show where M Bua may publish in the future.

Co-authorship network of co-authors of M Bua

This figure shows the co-authorship network connecting the top 25 collaborators of M Bua. A scholar is included among the top collaborators of M Bua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Bua. M Bua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Cristofori, Andrea Di, Francesca Raimondo, R Rigolio, et al.. (2024). Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells. International Journal of Molecular Sciences. 25(5). 2743–2743. 2 indexed citations
2.
Marín, David, Ian H Gabriel, Sohail Ahmad, et al.. (2011). KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. Leukemia. 26(2). 296–302. 41 indexed citations
3.
Auner, Holger W., Luca Mazzarella, Lucy Cook, et al.. (2010). High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma. Bone Marrow Transplantation. 46(3). 364–367. 18 indexed citations
4.
Milojković, Dragana, Emma Nicholson, Jane F. Apperley, et al.. (2009). Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Haematologica. 95(2). 224–231. 80 indexed citations
5.
Simula, Maria Paola, Sarah Marktel, Claudio Fozza, et al.. (2007). Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia. 21(5). 943–948. 34 indexed citations
7.
Marín, David, Sarah Marktel, M Bua, et al.. (2003). Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa. Leukemia. 17(8). 1448–1453. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026